Kazia Therapeutics Ownership 2024 | Who Owns Kazia Therapeutics Now?

Institutional Ownership

0.03%

Institutional Holders

6.00

Kazia Therapeutics Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
MORGAN STANLEY	0.11%	-	197,850	-3,700	-1.84%	61,294	Mar 31, 2024
HSBC HOLDINGS PLC	0.04%	-	63,956	-36,238	-36.17%	20,114	Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC	0.03%	-	48,600	35,900	282.68%	15,056	Mar 31, 2024
XTX TOPCO LTD	0.01%	0.00%	18,487	-949	-4.88%	5,814	Mar 31, 2024
TWO SIGMA SECURITIES, LLC	0.01%	0.00%	18,424	-39,999	-68.46%	5,708	Mar 31, 2024
RHUMBLINE ADVISERS	0.01%	-	12,170	2,460	25.33%	3,831,000	Mar 31, 2024
GROUND SWELL CAPITAL, LLC	0.01%	0.00%	11,150	11,150	100.00%	3,507	Mar 31, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	500	500	100.00%	155,000	Mar 31, 2024
ALLWORTH FINANCIAL LP	-	-	87	-	-	27,000	Mar 31, 2024
ADVISORNET FINANCIAL, INC	-	-	5	-	-	2,000	Mar 31, 2024
JPMORGAN CHASE & CO	-	-	3	3	100.00%	1	Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-18,682	-100.00%	-	Mar 31, 2024
BANK OF MONTREAL /CAN/	-	-	-	-140,166	-100.00%	-	Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD	-	-	-	-1,821,887	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-2,200	-100.00%	-	Mar 31, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-2,475,555	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-100	-100.00%	-	Mar 31, 2024
NEWEDGE ADVISORS, LLC	-	-	-	-500	-100.00%	-	Mar 31, 2024
MCGLONE SUTTNER WEALTH MANAGEMENT, INC.	-	-	-	-85	-100.00%	-	Mar 31, 2024

Kazia Therapeutics's largest institutional shareholder is MORGAN STANLEY, holding 0.11% of the company's total share outstanding, currently valued at $61.29K. The top 10 institutional shareholders own together 0.20% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GROUND SWELL CAPITAL, LLC	0.01%	0.00%	11,150	11,150	100.00%	3,507	Mar 31, 2024
XTX TOPCO LTD	0.01%	0.00%	18,487	-949	-4.88%	5,814	Mar 31, 2024
TWO SIGMA SECURITIES, LLC	0.01%	0.00%	18,424	-39,999	-68.46%	5,708	Mar 31, 2024
HSBC HOLDINGS PLC	0.04%	-	63,956	-36,238	-36.17%	20,114	Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC	0.03%	-	48,600	35,900	282.68%	15,056	Mar 31, 2024
MORGAN STANLEY	0.11%	-	197,850	-3,700	-1.84%	61,294	Mar 31, 2024
RHUMBLINE ADVISERS	0.01%	-	12,170	2,460	25.33%	3,831,000	Mar 31, 2024
ADVISORNET FINANCIAL, INC	-	-	5	-	-	2,000	Mar 31, 2024
ALLWORTH FINANCIAL LP	-	-	87	-	-	27,000	Mar 31, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	500	500	100.00%	155,000	Mar 31, 2024
JPMORGAN CHASE & CO	-	-	3	3	100.00%	1	Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-18,682	-100.00%	-	Mar 31, 2024
BANK OF MONTREAL /CAN/	-	-	-	-140,166	-100.00%	-	Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD	-	-	-	-1,821,887	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-2,200	-100.00%	-	Mar 31, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-2,475,555	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-100	-100.00%	-	Mar 31, 2024
NEWEDGE ADVISORS, LLC	-	-	-	-500	-100.00%	-	Mar 31, 2024
MCGLONE SUTTNER WEALTH MANAGEMENT, INC.	-	-	-	-85	-100.00%	-	Mar 31, 2024

The largest Kazia Therapeutics shareholder by % of total assets is GROUND SWELL CAPITAL, LLC. The company owns 11.15K shares of Kazia Therapeutics (KZIA), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
BNP PARIBAS ARBITRAGE, SNC	0.03%	-	48,600	35,900	282.68%	15,056	Mar 31, 2024
GROUND SWELL CAPITAL, LLC	0.01%	0.00%	11,150	11,150	100.00%	3,507	Mar 31, 2024
RHUMBLINE ADVISERS	0.01%	-	12,170	2,460	25.33%	3,831,000	Mar 31, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	500	500	100.00%	155,000	Mar 31, 2024
JPMORGAN CHASE & CO	-	-	3	3	100.00%	1	Mar 31, 2024
ALLWORTH FINANCIAL LP	-	-	87	-	-	27,000	Mar 31, 2024
ADVISORNET FINANCIAL, INC	-	-	5	-	-	2,000	Mar 31, 2024
MCGLONE SUTTNER WEALTH MANAGEMENT, INC.	-	-	-	-85	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-100	-100.00%	-	Mar 31, 2024
NEWEDGE ADVISORS, LLC	-	-	-	-500	-100.00%	-	Mar 31, 2024
XTX TOPCO LTD	0.01%	0.00%	18,487	-949	-4.88%	5,814	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-2,200	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	0.11%	-	197,850	-3,700	-1.84%	61,294	Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-18,682	-100.00%	-	Mar 31, 2024
HSBC HOLDINGS PLC	0.04%	-	63,956	-36,238	-36.17%	20,114	Mar 31, 2024
TWO SIGMA SECURITIES, LLC	0.01%	0.00%	18,424	-39,999	-68.46%	5,708	Mar 31, 2024
BANK OF MONTREAL /CAN/	-	-	-	-140,166	-100.00%	-	Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD	-	-	-	-1,821,887	-100.00%	-	Mar 31, 2024
ARMISTICE CAPITAL, LLC	-	-	-	-2,475,555	-100.00%	-	Mar 31, 2024

As of Mar 31 2024, Kazia Therapeutics's largest institutional buyer is BNP PARIBAS ARBITRAGE, SNC. The company purchased 35.90K stocks of KZIA, valued at $15.06K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	-	-	-	-2,475,555	-100.00%	-	Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD	-	-	-	-1,821,887	-100.00%	-	Mar 31, 2024
BANK OF MONTREAL /CAN/	-	-	-	-140,166	-100.00%	-	Mar 31, 2024
TWO SIGMA SECURITIES, LLC	0.01%	0.00%	18,424	-39,999	-68.46%	5,708	Mar 31, 2024
HSBC HOLDINGS PLC	0.04%	-	63,956	-36,238	-36.17%	20,114	Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-18,682	-100.00%	-	Mar 31, 2024
MORGAN STANLEY	0.11%	-	197,850	-3,700	-1.84%	61,294	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-2,200	-100.00%	-	Mar 31, 2024
XTX TOPCO LTD	0.01%	0.00%	18,487	-949	-4.88%	5,814	Mar 31, 2024
NEWEDGE ADVISORS, LLC	-	-	-	-500	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-100	-100.00%	-	Mar 31, 2024
MCGLONE SUTTNER WEALTH MANAGEMENT, INC.	-	-	-	-85	-100.00%	-	Mar 31, 2024
ADVISORNET FINANCIAL, INC	-	-	5	-	-	2,000	Mar 31, 2024
ALLWORTH FINANCIAL LP	-	-	87	-	-	27,000	Mar 31, 2024
JPMORGAN CHASE & CO	-	-	3	3	100.00%	1	Mar 31, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	500	500	100.00%	155,000	Mar 31, 2024
RHUMBLINE ADVISERS	0.01%	-	12,170	2,460	25.33%	3,831,000	Mar 31, 2024
GROUND SWELL CAPITAL, LLC	0.01%	0.00%	11,150	11,150	100.00%	3,507	Mar 31, 2024
BNP PARIBAS ARBITRAGE, SNC	0.03%	-	48,600	35,900	282.68%	15,056	Mar 31, 2024

As of Mar 31 2024, Kazia Therapeutics's biggest institutional seller is ARMISTICE CAPITAL, LLC. The company sold -2.48M shares of KZIA, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
GROUND SWELL CAPITAL, LLC	0.01%	0.00%	11,150	11,150	100.00%	3,507	Mar 31, 2024
WELLS FARGO & COMPANY/MN	0.00%	-	500	500	100.00%	155,000	Mar 31, 2024
JPMORGAN CHASE & CO	-	-	3	3	100.00%	1	Mar 31, 2024

Kazia Therapeutics's largest new institutional shareholder by number of shares is GROUND SWELL CAPITAL, LLC, purchased 11.15K shares, valued at $3.51K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ARMISTICE CAPITAL, LLC	-	-	-	-2,475,555	-100.00%	-	Mar 31, 2024
PLATINUM INVESTMENT MANAGEMENT LTD	-	-	-	-1,821,887	-100.00%	-	Mar 31, 2024
BANK OF MONTREAL /CAN/	-	-	-	-140,166	-100.00%	-	Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC	-	-	-	-18,682	-100.00%	-	Mar 31, 2024
CITADEL ADVISORS LLC	-	-	-	-2,200	-100.00%	-	Mar 31, 2024
NEWEDGE ADVISORS, LLC	-	-	-	-500	-100.00%	-	Mar 31, 2024
UBS GROUP AG	-	-	-	-100	-100.00%	-	Mar 31, 2024
MCGLONE SUTTNER WEALTH MANAGEMENT, INC.	-	-	-	-85	-100.00%	-	Mar 31, 2024

Kazia Therapeutics's largest sold out institutional shareholder by shares sold is ARMISTICE CAPITAL, LLC, sold -2.48M shares, valued at -, as of undefined.

Kazia Therapeutics Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
TRUST FOR PROFESSIONAL MANAGERS	0.00%	26,411	-	-	Feb 29, 2024
FIDELITY CONCORD STREET TRUST	0.00%	4,948	-	-	Feb 29, 2024

Kazia Therapeutics's largest mutual fund holder by % of total assets is "TRUST FOR PROFESSIONAL MANAGERS", owning 26.41K shares, compromising 0.00% of its total assets.

Kazia Therapeutics Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 24	6	-66.67%
31 Dec, 23	18	80.00%
30 Sep, 23	10	11.11%
30 Jun, 23	9	12.50%
31 Mar, 23	8	-11.11%
31 Dec, 22	9	28.57%
30 Sep, 22	7	-36.36%
30 Jun, 22	11	10.00%
31 Mar, 22	10	-
31 Dec, 21	10	-33.33%
30 Sep, 21	15	36.36%
30 Jun, 21	11	10.00%
31 Mar, 21	10	-16.67%
31 Dec, 20	12	20.00%
30 Sep, 20	10	66.67%
30 Jun, 20	6	-
31 Mar, 20	6	-25.00%
31 Dec, 19	8	14.29%
30 Sep, 19	7	-
30 Jun, 19	7	40.00%
31 Mar, 19	5	-
31 Dec, 18	5	-28.57%
30 Sep, 18	7	-
30 Jun, 18	7	16.67%
31 Mar, 18	6	50.00%
31 Dec, 17	4	-

As of 31 Mar 24, 6 institutions are holding Kazia Therapeutics's shares, representing a decrease of -66.67% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 24	61,365	-98.74%
31 Dec, 23	4,883,338	1959.24%
30 Sep, 23	237,143	-16.63%
30 Jun, 23	284,444	4.77%
31 Mar, 23	271,491	-36.29%
31 Dec, 22	426,146	-11.34%
30 Sep, 22	480,663	63.33%
30 Jun, 22	294,297	-16.16%
31 Mar, 22	351,036	-17.39%
31 Dec, 21	424,950	-17.56%
30 Sep, 21	515,465	-1.26%
30 Jun, 21	522,021	21.08%
31 Mar, 21	431,151	-20.46%
31 Dec, 20	542,077	22.62%
30 Sep, 20	442,094	42.70%
30 Jun, 20	309,803	18.74%
31 Mar, 20	260,899	4.20%
31 Dec, 19	250,372	-1.20%
30 Sep, 19	253,418	11.53%
30 Jun, 19	227,222	10.75%
31 Mar, 19	205,165	-0.36%
31 Dec, 18	205,915	-1.86%
30 Sep, 18	209,825	89.66%
30 Jun, 18	110,632	16.86%
31 Mar, 18	94,669	11.86%
31 Dec, 17	84,629	-

Kazia Therapeutics (KZIA) has 61.37K shares outstanding as of 31 Mar 24, down -98.74% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 24	0.03%	0.70%
31 Dec, 23	2.19%	68.36%
30 Sep, 23	1.79%	38.83%
30 Jun, 23	2.15%	51.12%
31 Mar, 23	2.05%	19.80%
31 Dec, 22	3.22%	24.43%
30 Sep, 22	3.63%	73.52%
30 Jun, 22	2.22%	31.64%
31 Mar, 22	2.65%	25.75%
31 Dec, 21	3.21%	16.72%
30 Sep, 21	4.38%	22.26%
30 Jun, 21	4.44%	45.34%
31 Mar, 21	3.13%	20.23%
31 Dec, 20	3.93%	10.74%
30 Sep, 20	6.05%	33.65%
30 Jun, 20	4.24%	33.25%
31 Mar, 20	3.57%	30.40%
31 Dec, 19	3.43%	17.65%
30 Sep, 19	4.41%	28.23%
30 Jun, 19	3.95%	31.04%
31 Mar, 19	3.57%	27.83%
31 Dec, 18	3.58%	19.03%
30 Sep, 18	4.34%	82.93%
30 Jun, 18	2.29%	59.72%
31 Mar, 18	1.96%	63.94%
31 Dec, 17	1.75%	-

As of 31 Mar 24, Kazia Therapeutics is held by 0.03% institutional shareholders, representing a 0.70% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 24	4	-66.67%
31 Dec, 23	12	500.00%
30 Sep, 23	2	-33.33%
30 Jun, 23	3	-
31 Mar, 23	3	-57.14%
31 Dec, 22	7	40.00%
30 Sep, 22	5	66.67%
30 Jun, 22	3	-25.00%
31 Mar, 22	4	-20.00%
31 Dec, 21	5	-16.67%
30 Sep, 21	6	-14.29%
30 Jun, 21	7	75.00%
31 Mar, 21	4	-42.86%
31 Dec, 20	7	-
30 Sep, 20	7	133.33%
30 Jun, 20	3	50.00%
31 Mar, 20	2	-50.00%
31 Dec, 19	4	100.00%
30 Sep, 19	2	-33.33%
30 Jun, 19	3	200.00%
31 Mar, 19	1	-
31 Dec, 18	1	-66.67%
30 Sep, 18	3	-
30 Jun, 18	3	-
31 Mar, 18	3	-25.00%
31 Dec, 17	4	-

4 institutional shareholders have increased their position in KZIA stock as of 31 Mar 24 compared to 12 in the previous quarter (a -66.67% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 24	-	-100.00%
31 Dec, 23	1	-50.00%
30 Sep, 23	2	-
30 Jun, 23	-	-100.00%
31 Mar, 23	3	50.00%
31 Dec, 22	2	-
30 Sep, 22	2	-60.00%
30 Jun, 22	5	66.67%
31 Mar, 22	3	-
31 Dec, 21	3	50.00%
30 Sep, 21	2	100.00%
30 Jun, 21	1	-66.67%
31 Mar, 21	3	50.00%
31 Dec, 20	2	100.00%
30 Sep, 20	1	-
30 Jun, 20	-	-100.00%
31 Mar, 20	1	-
31 Dec, 19	-	-100.00%
30 Sep, 19	1	-
30 Jun, 19	1	-
31 Mar, 19	1	-
31 Dec, 18	1	-50.00%
30 Sep, 18	2	-
30 Jun, 18	-	-100.00%
31 Mar, 18	1	-
31 Dec, 17	-	-

- institutional shareholders have reduced their position in KZIA stock as of 31 Mar 24 compared to 1 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 24	6	-66.67%	61,365	-98.74%	0.03%	0.70%	4	-66.67%	-	-100.00%
31 Dec, 23	18	80.00%	4,883,338	1959.24%	2.19%	68.36%	12	500.00%	1	-50.00%
30 Sep, 23	10	11.11%	237,143	-16.63%	1.79%	38.83%	2	-33.33%	2	-
30 Jun, 23	9	12.50%	284,444	4.77%	2.15%	51.12%	3	-	-	-100.00%
31 Mar, 23	8	-11.11%	271,491	-36.29%	2.05%	19.80%	3	-57.14%	3	50.00%
31 Dec, 22	9	28.57%	426,146	-11.34%	3.22%	24.43%	7	40.00%	2	-
30 Sep, 22	7	-36.36%	480,663	63.33%	3.63%	73.52%	5	66.67%	2	-60.00%
30 Jun, 22	11	10.00%	294,297	-16.16%	2.22%	31.64%	3	-25.00%	5	66.67%
31 Mar, 22	10	-	351,036	-17.39%	2.65%	25.75%	4	-20.00%	3	-
31 Dec, 21	10	-33.33%	424,950	-17.56%	3.21%	16.72%	5	-16.67%	3	50.00%
30 Sep, 21	15	36.36%	515,465	-1.26%	4.38%	22.26%	6	-14.29%	2	100.00%
30 Jun, 21	11	10.00%	522,021	21.08%	4.44%	45.34%	7	75.00%	1	-66.67%
31 Mar, 21	10	-16.67%	431,151	-20.46%	3.13%	20.23%	4	-42.86%	3	50.00%
31 Dec, 20	12	20.00%	542,077	22.62%	3.93%	10.74%	7	-	2	100.00%
30 Sep, 20	10	66.67%	442,094	42.70%	6.05%	33.65%	7	133.33%	1	-
30 Jun, 20	6	-	309,803	18.74%	4.24%	33.25%	3	50.00%	-	-100.00%
31 Mar, 20	6	-25.00%	260,899	4.20%	3.57%	30.40%	2	-50.00%	1	-
31 Dec, 19	8	14.29%	250,372	-1.20%	3.43%	17.65%	4	100.00%	-	-100.00%
30 Sep, 19	7	-	253,418	11.53%	4.41%	28.23%	2	-33.33%	1	-
30 Jun, 19	7	40.00%	227,222	10.75%	3.95%	31.04%	3	200.00%	1	-
31 Mar, 19	5	-	205,165	-0.36%	3.57%	27.83%	1	-	1	-
31 Dec, 18	5	-28.57%	205,915	-1.86%	3.58%	19.03%	1	-66.67%	1	-50.00%
30 Sep, 18	7	-	209,825	89.66%	4.34%	82.93%	3	-	2	-
30 Jun, 18	7	16.67%	110,632	16.86%	2.29%	59.72%	3	-	-	-100.00%
31 Mar, 18	6	50.00%	94,669	11.86%	1.96%	63.94%	3	-25.00%	1	-
31 Dec, 17	4	-	84,629	-	1.75%	-	4	-	-	-

Kazia Therapeutics Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Nov 06, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	25,400	$6.02	$153.03K	409,671
Nov 06, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	23,922	$6.01	$143.69K	385,749
Oct 29, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	62,591	$6.17	$386.34K	473,580
Oct 29, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	37,409	$6.18	$231.24K	436,171
Oct 29, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	1,100	$6.04	$6.64K	435,071
Oct 17, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	90,025	$6.21	$559.21K	536,171
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$8.90	$4.45K	629,196
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.05	$4.53K	628,696
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.10	$4.55K	628,196
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.15	$4.58K	627,696
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.21	$4.61K	627,196
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.03	$4.51K	626,696
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$8.00	$4.00K	626,196
Jul 31, 2008	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	4,531,633	$1.16	$5.26M	20,323,053
Mar 27, 2008	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	7,000	$4.90	$34.28K	3,158,284
Sep 11, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	435,039	$7.76	$3.38M	3,151,284
Jul 12, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	200,000	$8.39	$1.68M	2,716,245
Jul 02, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	24,100	$8.40	$202.44K	2,516,245
Jun 26, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	7,000	$8.60	$60.18K	2,492,145
Jun 22, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	4,183	$8.48	$35.46K	2,485,145

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 31, 2008	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	4,531,633	$1.16	$5.26M	20,323,053
Mar 27, 2008	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	7,000	$4.90	$34.28K	3,158,284
Sep 11, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	435,039	$7.76	$3.38M	3,151,284
Jul 12, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	200,000	$8.39	$1.68M	2,716,245
Jul 02, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	24,100	$8.40	$202.44K	2,516,245
Jun 26, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	7,000	$8.60	$60.18K	2,492,145
Jun 22, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	4,183	$8.48	$35.46K	2,485,145

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Nov 06, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	25,400	$6.02	$153.03K	409,671
Nov 06, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	23,922	$6.01	$143.69K	385,749
Oct 29, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	62,591	$6.17	$386.34K	473,580
Oct 29, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	37,409	$6.18	$231.24K	436,171
Oct 29, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	1,100	$6.04	$6.64K	435,071
Oct 17, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	90,025	$6.21	$559.21K	536,171
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$8.90	$4.45K	629,196
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.05	$4.53K	628,696
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.10	$4.55K	628,196
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.15	$4.58K	627,696
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.21	$4.61K	627,196
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.03	$4.51K	626,696
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$8.00	$4.00K	626,196

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Nov 06, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	25,400	$6.02	$153.03K	409,671
Nov 06, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	23,922	$6.01	$143.69K	385,749
Oct 29, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	62,591	$6.17	$386.34K	473,580
Oct 29, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	37,409	$6.18	$231.24K	436,171
Oct 29, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	1,100	$6.04	$6.64K	435,071
Oct 17, 2013	AUSTIN JOSIAH T	10 percent owner	-	S-Sale	Sell	90,025	$6.21	$559.21K	536,171
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$8.90	$4.45K	629,196
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.05	$4.53K	628,696
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.10	$4.55K	628,196
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.15	$4.58K	627,696
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.21	$4.61K	627,196
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$9.03	$4.51K	626,696
Feb 27, 2013	AUSTIN JOSIAH T	director, 10 percent owner		S-Sale	Sell	500	$8.00	$4.00K	626,196
Jul 31, 2008	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	4,531,633	$1.16	$5.26M	20,323,053
Mar 27, 2008	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	7,000	$4.90	$34.28K	3,158,284
Sep 11, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	435,039	$7.76	$3.38M	3,151,284
Jul 12, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	200,000	$8.39	$1.68M	2,716,245
Jul 02, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	24,100	$8.40	$202.44K	2,516,245
Jun 26, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	7,000	$8.60	$60.18K	2,492,145
Jun 22, 2007	AUSTIN JOSIAH T	10 percent owner	-	P-Purchase	Buy	4,183	$8.48	$35.46K	2,485,145

The last insider sell of Kazia Therapeutics's stock was made by AUSTIN JOSIAH T on Nov 06 2013, selling 25,400 shares at $6.02 per share (valued at $153.03K). The last insider buy of KZIA was made by AUSTIN JOSIAH T on Jul 31 2008, buying 4,531,633 shares at $1.16 per share (worth $5.26M).

Kazia Therapeutics Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2013	-	6	-
Q1 2013	-	7	-
Q4 2012	1	2	50.00%
Q2 2012	2	1	200.00%
Q4 2011	1	-	-
Q3 2011	1	-	-
Q2 2011	1	-	-
Q3 2008	2	-	-
Q1 2008	1	-	-
Q3 2007	2	-	-
Q2 2007	30	-	-
Q1 2007	16	-	-
Q4 2006	26	-	-
Q3 2006	8	-	-
Q2 2006	8	1	800.00%
Q1 2006	-	1	-
Q4 2003	-	1	-

0 total buy trades, and 6 total sell trades (buy/sell ratio of 0.00%) were made by Kazia Therapeutics's insiders, as of Q4 2013.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q4 2013	-	6	-
Q1 2013	-	7	-
Q4 2012	-	-	-
Q2 2012	-	-	-
Q4 2011	-	-	-
Q3 2011	-	-	-
Q2 2011	1	-	-
Q3 2008	2	-	-
Q1 2008	1	-	-
Q3 2007	2	-	-
Q2 2007	30	-	-
Q1 2007	16	-	-
Q4 2006	26	-	-
Q3 2006	8	-	-
Q2 2006	8	-	-
Q1 2006	-	-	-
Q4 2003	-	-	-

As of Q4 2013, Insider owners conducted 0 open market buy trades and 6 open market sell trades of Kazia Therapeutics's stocks.

Kazia Therapeutics Peer Ownership

Ticker	Company
ANEB	Anebulo Pharmaceuticals, Inc.
OKYO	OKYO Pharma Limited
QNRX	Quoin Pharmaceuticals, Ltd.
SPRO	Spero Therapeutics, Inc.
QSI	Quantum-Si incorporated
MREO	Mereo BioPharma Group plc
HCWB	HCW Biologics Inc.
OCUL	Ocular Therapeutix, Inc.
SEER	Seer, Inc.
NLSP	NLS Pharmaceutics AG
RNXT	RenovoRx, Inc.
CADL	Candel Therapeutics, Inc.
DAWN	Day One Biopharmaceuticals, Inc.
SLS	SELLAS Life Sciences Group, Inc.
NRIX	Nurix Therapeutics, Inc.
KTTA	Pasithea Therapeutics Corp.
CTMX	CytomX Therapeutics, Inc.
ACHL	Achilles Therapeutics plc
MNOV	MediciNova, Inc.
ASMB	Assembly Biosciences, Inc.
ABIO	ARCA biopharma, Inc.

KZIA Ownership FAQ

Who Owns Kazia Therapeutics?

Kazia Therapeutics is owned by institutional shareholders (0.03%), insiders (0.00%), and public (99.97%). The largest institutional shareholder of Kazia Therapeutics is MORGAN STANLEY (0.11% of total shares) and the top mutual fund owner is TRUST FOR PROFESSIONAL MANAGERS (0.00% of total shares).

Who are the major institutional shareholders of Kazia Therapeutics?

Kazia Therapeutics's major institutional shareholders are MORGAN STANLEY, HSBC HOLDINGS PLC, BNP PARIBAS ARBITRAGE, SNC, XTX TOPCO LTD, and TWO SIGMA SECURITIES, LLC. The top five shareholders own together 0.19% of the company's share outstanding.

How many Kazia Therapeutics shareholders are there?

As of Mar 2024, there are 6 institutional shareholders of Kazia Therapeutics.

What percentage of Kazia Therapeutics is owned by MORGAN STANLEY?

MORGAN STANLEY owns 197.85K shares of Kazia Therapeutics, representing 0.11% of the company's total shares outstanding, valued at $61.29K (as of Mar 2024).

What percentage of Kazia Therapeutics is owned by HSBC HOLDINGS PLC?

As of Mar 2024, HSBC HOLDINGS PLC holds 63.96K shares of Kazia Therapeutics (KZIA), compromising 0.04% of the company, valued at $20.11K.

What percentage of Kazia Therapeutics is owned by BNP PARIBAS ARBITRAGE, SNC?

BNP PARIBAS ARBITRAGE, SNC is the third largest holder of Kazia Therapeutics. The company owns 48.6K of the company's shares outstanding (worth $15.06K).